Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Bibliographic Details
Main Author: Flora, Sanzida Alam
Other Authors: Azam, Faruque
Format: Thesis
Language:English
Published: Brac University 2024
Subjects:
NSCLC
Tyrosine kinase inhibitor
Efficacy endpoints
Cancer therapy
Lung cancer
Lung cancer > Treatment
Protein-tyrosine kinase > Inhibitors > Therapeutic use
Online Access:http://hdl.handle.net/10361/23693

Internet

http://hdl.handle.net/10361/23693

Similar Items